1887
Volume 2022, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) has become a threat to public health. People with chronic diseases, such as diabetes, are at a greater risk of severe diseases and death upon contracting this new disease. Due to the novelty of COVID-19, no specific information is available about the degree of its mortality and risk factors among diabetic patients. Therefore, this study aims to compare diabetic and nondiabetic COVID-19 patients regarding mortality rate, the need for intensive care unit (ICU) admission, invasive and noninvasive ventilation, and the associated risk factors.

Methods: This was a cross-sectional study performed on the medical records of 650 adult COVID-19 patients (325 diabetics and 325 nondiabetics) admitted to Razi Hospital in Ahvaz from March 2020 to September 2020.

Results: The mean age of the patients was 61.3 years in the diabetic group and 52.3 years in the nondiabetic group. Men comprised 48.3% of the diabetic group and 59.7% of the nondiabetic group. Diabetic patients suffered from significantly more underlying diseases, such as ischemic heart disease (IHD), hypertension (HTN), chronic kidney disease (CKD), and acute renal failure (ARF) compared to the nondiabetic group ( < 0.0001). Also, when compared with the nondiabetic group, the diabetic group had a significantly higher mortality rate (17.5% vs. 12%;  = 0.047, respectively), more ICU admissions (35.4% vs. 27.7%;  = 0.035, respectively), and a greater need for invasive ventilation (17.5% vs. 11.4%;  = 0.026, respectively).

Conclusion: In diabetic patients, the mortality rate, need for ICU admission, and need for invasive ventilation were significantly higher than nondiabetic patients. Our logistic regression analysis in diabetic patients with COVID-19 showed that age, CKD, and ARF were the risk factors affecting mortality. In contrast, age and CKD were the risk factors affecting the rate of ICU admission, and CKD and ARF were the risk factors affecting the need for invasive ventilation.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.9
2022-03-01
2022-05-17
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/1/qmj.2022.9.html?itemId=/content/journals/10.5339/qmj.2022.9&mimeType=html&fmt=ahah

References

  1. Egbi OG, Adejumo OA, Akinbodewa AA. Coronavirus infection and kidney disease: a review of current and emerging evidence. Pan Afr Med J. 2020; 13:(37):149.
    [Google Scholar]
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:(10223):497–506.
    [Google Scholar]
  3. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020 Feb 20; 9:(1):19.
    [Google Scholar]
  4. Ceccarelli M, Berretta M, Venanzi Rullo E, Nunnari G, Cacopardo B. Differences and similarities between severe acute respiratory syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 2020; 24:(5):2781–3.
    [Google Scholar]
  5. Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besançon S, et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2020; 162:108072.
    [Google Scholar]
  6. Abolnezhadian F, Hosseini SA, Alipour M, Zakerkish M, Cheraghian B, Ghandil P, et al. Association metabolic obesity phenotypes with cardiometabolic index, atherogenic index of plasma and novel anthropometric indices: a link of FTO-rs9939609 polymorphism. Vasc Health Risk Manag. 2020;16:249–256.
    [Google Scholar]
  7. McDonald HI, Nitsch D, Millett ER, Sinclair A, Thomas SL. New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabet Med. 2014; 31:(5):606–14.
    [Google Scholar]
  8. Li S, Wang J, Zhang B, Li X, Liu Y. Diabetes mellitus and cause-specific mortality: a population-based study. Diabetes Metab J. 2019; 43:(3):319–41.
    [Google Scholar]
  9. Antonio Toniolo, Gianluca Cassani, Anna Puggioni, Agostino Rossi, Alberto Colombo, Takashi Onodera, et al. The diabetes pandemic and associated infections: suggestions for clinical microbiology. Rev Med Microbiol. 2019 Jan; 30:(1): 1–17.
    [Google Scholar]
  10. Schoen K, Horvat N, Guerreiro NFC, de Castro I, de Giassi KS. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis. 2019; 19:(1):964.
    [Google Scholar]
  11. Banik GR, Alqahtani AS, Booy R, Rashid H. Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia. Virol Sin. 2016; 31:(1):81–4.
    [Google Scholar]
  12. Angelidi AM, Belanger MJ, Mantzoros CS. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next. Metabolism. 2020;107:154245.
    [Google Scholar]
  13. Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes care. 2020; 43:(7):1382–91.
    [Google Scholar]
  14. Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol. 2020 Jul 22;:11:1582.
    [Google Scholar]
  15. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020; 14:(4):395–403.
    [Google Scholar]
  16. Meysam A, Hosein R, Karim P. Association between inflammatory obesity phenotypes, FTO-rs9939609, and cardiovascular risk factors in patients with type 2 diabetes. J Res Med Sci. 2020;25:46.
    [Google Scholar]
  17. Li G, Deng Q, Feng J, Li F, Xiong N, He Q. Clinical characteristics of diabetic patients with COVID-19. J Diabetes Res. 2020;2020:1652403.
    [Google Scholar]
  18. Lei M, Lin K, Pi Y, Huang X, Fan L, Huang J, et al. Clinical features and risk factors of ICU admission for COVID-19 patients with diabetes. J Diabetes Res. 2020;2020:5237840.
    [Google Scholar]
  19. Ciardullo S, Zerbini F, Perra S, Muraca E, Cannistraci R, Lauriola M, et al. Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy. J Endocrinol Invest. 2020; 44:(4):843–850.
    [Google Scholar]
  20. Izzi-Engbeaya C, Distaso W, Amin A, Yang W, Idowu O, Kenkre JS, et al. Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals. BMJ Open Diabetes Res Care. 2021; 9:(1):e001858.
    [Google Scholar]
  21. Acharya D, Lee K, Lee DS, Lee YS, Moon S-S, editors. Mortality rate and predictors of mortality in hospitalized COVID-19 patients with diabetes. Healthcare; 2020: Multidisciplinary Digital Publishing Institute.
    [Google Scholar]
  22. Nicholson CJ, Wooster L, Sigurslid HH, Li RH, Jiang W, Tian W, et al. Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham: The VICE and DICE scores. EClinicalMedicine. 2021;33:100765.
    [Google Scholar]
  23. Mansour A, Sajjadi-Jazi SM, Kasaeian A, Khosravi B, Sorouri M, Azizi F, et al. Clinical characteristics and outcomes of diabetics hospitalized for COVID-19 infection: a single-centered, retrospective, observational study. EXCLI J. 2020;19:1533.
    [Google Scholar]
  24. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020; 75:(18):2352–71.
    [Google Scholar]
  25. Li M, Dong Y, Wang H, Guo W, Zhou H, Zhang Z, et al. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutrition, Metabolism and Cardiovascular Diseases. 2020; 30:(7):1061–7.
    [Google Scholar]
  26. Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020; 17:(5):259-60.
    [Google Scholar]
  27. Jing-Yi Qian, Bin Wang, Lin-Li Lv, Bi-Cheng Liu. Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019. Front Physiol. 2021; 12: 586589.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2022.9
Loading
/content/journals/10.5339/qmj.2022.9
Loading

Data & Media loading...

Keyword(s): COVID-19deathdiabetesICU and invasive ventilation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error